Table 6Comparison of costs and consequences

Strategy AStrategy BStrategy C
costs£1,225,990£1,301,837£2,159,867
effectiveness530561602
average cost effectiveness£2313.18£2320.56£3587.818
incremental effectiveness3141
incremental costs£75,846£858,030
incremental cost effectiveness£2,446.66£20,927.56*
*

Compared with strategy B

From: Appendix C, The Health Economics of Referral for Suspected Colorectal Cancer

Cover of Referral Guidelines for Suspected Cancer in Adults and Children
Referral Guidelines for Suspected Cancer in Adults and Children [Internet].
NICE Clinical Guidelines, No. 27.
Clinical Governance Research and Development Unit (CGRDU), Department of Health Sciences, University of Leicester.
Copyright © 2005, National Collaborating Centre for Primary Care.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.